The 28th Annual Meeting of the Japanese Society
for Biomedical Mass Spectrometry
Program | September
25 (Thu.) |
Japanesee |
@
September
26 (Fri.) |
9:00 | Oral Presentation X
(G18|G21) |
G18 | Identifications of modified octapeptides containing cysteine of transthyretin |
by iontrap tandem mass spectrometry | |
Toyofumi NAKANISHI1ETakako SATO1E2EAkira SHIMIZU1 | |
1Department of Clinical Pathology, Osaka Medical College | |
2Department of Neurology, Osaka University Graduate School of Medicine | |
G19 | Quantitative measurement of hemoglobin A1c by stable isotope dilution |
method | |
Ken IGUCHI1EToyofumi NAKANIAHI2EAkira SHIMIZU1E2 | |
1Central Clinical Laboratory, Osaka Medical College Hospital | |
2Department of Clinical Pathology, Osaka Medical College | |
G20 | Detection of S-homocysteinyl transthyretin in plasma and serum from |
patients
with hyperhomocysteinemia by LC-ESIMS |
|
Takako SATO1EToyofumi NAKANISHI2EJorn Oliver SASS3ESaburo SAKODA1 | |
Akira SHIMIZU2 | |
1Department of Neurology, Osaka University Graduate School of Medicine | |
2Department of Clinical Pathology, Osaka Medical College | |
3University of Freiburg Childrenfs Hospital, Laboratory of Metabolism, | |
Germany | |
G21 | Analysis of medium chain acyl-CoA synthetase by LC-ESI-MS/MS |
Fumiyo KASUYA1ETakao TATSUKI1EKyoko SASAKI2EYoji KITAMURA1EKazuo |
|
IGARASHI1 | |
1Faculty of Pharmaceutical Sciences, Kobegakuin University | |
2Jasco International Co., Ltd. |
10:00 | Oral Presentation Y
(G22|G25) |
G22 | Mass
spectrometric analysis of single nucleotide polymorphisms (SNPs) |
Kentaro TAKI1EIsao AOYAMA1EAtsushi ENOMOTO1EFumio TAKAYAMA1E | |
Naohito TAKEDA2EToshimitsu NIWA1 | |
1Department of Clinical Preventive Medicine, Nagoya University Hospital | |
2Faculty of Pharmacy, Meijo University | |
G23 | Evaluation of sphingolipids in vitreous body from a
patient with Gaucher |
disease by DE MALDI-TOF/MS | |
Takehisa FUJIWAKI1ESeiji YAMAGUCHI1EMasaru TASAKA1EMasaki | |
TAKAYANAGI2ETamotsu TAKETOMI3 | |
1Department of Pediatrics, Shimane Medical University | |
2Department of Pediatrics, Chiba Childrenfs Hospital | |
3Department of Biochemistry, Research Center on Aging and Adaptation, | |
Shinshu University School of Medicine | |
G24 | Semiquantification of ceramide trihexoside in aortic valve from patient with |
Fabry disease analyzed by MALDI-TOFMS | |
Masaru TASAKA1ETakehisa FUJIWAKI1ENobuyuki TAKAHASHI2EYou | |
MURAKAMI2EToshio SHIMADA2ESeiji YAMAGUCHI1 | |
1Department of Pediatrics, Shimane Medical University | |
2Cardiovascular Division of Internal Medicine, Shimane Medical University | |
G25 | Structure analysis of protein anchored on ibuprofen by MALDI-TOFMS and |
chiral characterication by immunoblotting | |
Shigeo IKEGAWA | |
Department of Bioanalytical Pharmaceutics, Faculty of Pharmaceutical | |
Sciences, Kinki University |
11:00 | Coffee Break |
@
11:10 | Special Lecture |
Drug facilitated sexual assault (DFSA) and toxicological analysis: testing for | |
the undetectable by mass spectrometry | |
Pascal KINTZ and Marion VILLAIN | |
Institut de Médecine Légale, 11 rue Humann, F-67000 Strasbourg, France |
@
12:00 |
Lunch Time |
@
13:30 | WorkshopU |
W2-1 | Characteristics of gChemo View Softwareh that automates neonatal screening |
using tandem mass spectrometry | |
Hidekazu MIYAKODA, Yuriko OZEKI, Tetsuo KOKAJI, Yasuhiko MAEKAWA | |
Applied Biosystems Japan Ltd. | |
W2-2 | An LC and LC/MS (n) system for proteomic analysis |
Hiroyuki MURAKITA, Junko IIDA | |
Analytical & Measuring Instruments Division, Shimadzu Corporation | |
W2-3 | State-of-the-art technologies for proteomics |
Masahiko TAKINO | |
Yokogawa Analytical Systems Inc., Application Center | |
W2-4 | Development and applications of CE-MS interface for LC-TOFMS |
Yutaka TAKAHASHI ETetsuichiro MORITAEKenji NAGATOMOEJunichi | |
OSUGAEKiyotaka KONUMAEJun
TAMURA |
|
JEOL Ltd. | |
W2-5 | Biomarker discovery using SELDI-TOF-MS |
Kenji SAITOH | |
Ciphergen Biosystems K.K. Yokohama Laboratory |
15:10 | Closing Remark |
@
@@